Current through Register Vol. 51, No. 22, November 1, 2024
Section 10.47.07.04 - Review of Prescription Monitoring DataA. The Program shall review prescription monitoring data and naloxone medication data for indications of possible: (1) Misuse or abuse of a monitored prescription drug; and(2) Violations of law or possible breaches of professional standards by a prescriber or a dispenser.B. In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.Md. Code Regs. 10.47.07.04
Regulation .04H amended effective October 28, 2013 (40:21 Md. R. 1775)
Regulation .04 amended effective 42:11 Md. R. 725, eff.6/8/2015; amended effective 47:10 Md. R. 519, eff. 5/18/2020; amended effective 50:8 Md. R. 338, eff. 7/20/2023